Pfizer : PFE

All Pfizer Articles

1534 Articles

Douglas A. McIntyre | Aug 7, 2007 at 3:16 AM EDT

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Bear Stearns (BSC) has several potential buyers including JP Morgan (JPM) and Bank of America (BAC) Reuters…

Douglas A. McIntyre | Aug 6, 2007 at 7:07 PM EDT

PFizer’s (PFE) Promising New HIV Drug

Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway…

Douglas A. McIntyre | Jul 20, 2007 at 3:27 AM EDT

NYSE Short Interest For July

Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007…

Douglas A. McIntyre | Jul 18, 2007 at 7:15 AM EDT

Pre-Market Stock News (July 18, 2007)

(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items;…

Douglas A. McIntyre | Jul 18, 2007 at 5:59 AM EDT

Pfizer’s (PFE) Bad Hair Day

Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48%…

Douglas A. McIntyre | Jul 13, 2007 at 4:58 PM EDT

Top Earnings Next Week Part 1 (July 16-18, 2007)

MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch (NYSE:MER)Novartis (NYSE:NVS/ADR)Pharmaceutical Product Development (NASDAQ:PPDI)SLM…

Douglas A. McIntyre | Jun 24, 2007 at 12:16 PM EDT

Mixed Short Interest in Drug & Medical Stocks (June 2007)

As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a…

Douglas A. McIntyre | Jun 22, 2007 at 8:41 AM EDT

DJIA Components Short Interest Mixed (June 2007)

Stock Tickers: AA, AIG, AXP, BA, C, CAT, DD, DIS, GE, GM, HD, HON, HPQ, IBK, JNJ, JPM, KO, MCD,…

Douglas A. McIntyre | Jun 22, 2007 at 3:16 AM EDT

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, the IPO for Blackstone priced at the high end of its range, raising $4.13 billion. Reuters writes…

Douglas A. McIntyre | Jun 21, 2007 at 7:13 PM EDT

NYSE Short Interest, June 2007

The NYSE released short interest in stocks traded on the exchange. The figures are as of June 15 and are…

Douglas A. McIntyre | Jun 21, 2007 at 3:30 AM EDT

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

According to Reuters, Home Depot (HD) weighed a cut in its credit rating against its decision to buy-back $22.5 billion…

Douglas A. McIntyre | Jun 20, 2007 at 7:39 PM EDT

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Coley Pharmaceuticals (COLY) is yet another small-cap biopharma one-trick pony that fell apart like a cheap clock. Pfizer (PFE) had…

Douglas A. McIntyre | Jun 20, 2007 at 4:37 PM EDT

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Shares of microcap biotech Coley Pharmaceutical Group (COLY-NASDAQ) saw shares get pounded late on Wednesday afternoon. Right before 2:00 PM…

Douglas A. McIntyre | Jun 12, 2007 at 5:53 PM EDT

Cramer’s Picks & Pans in Pharmaceuticals

Stock Tickers: MRK, PFE, JNJ, GSK, SGP, LLY, WYE, NVS, NVO On tonight’s MAD MONEY on CNBC, Jim Cramer said…

Douglas A. McIntyre | Jun 8, 2007 at 2:14 PM EDT

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Stock Tickers: AAPL, GOOG, RIMM, BA, UTX, ATI, RTP, RIO, FLR, SGR, PEP, KO, BUD, CAG, HNZ, CPB, HRL, K,…

1 … 100 101 102 103

Pfizer : PFE

All Pfizer Articles

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

PFizer’s (PFE) Promising New HIV Drug

NYSE Short Interest For July

Pre-Market Stock News (July 18, 2007)

Pfizer’s (PFE) Bad Hair Day

Top Earnings Next Week Part 1 (July 16-18, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

DJIA Components Short Interest Mixed (June 2007)

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

NYSE Short Interest, June 2007

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Born in 1960 or Later? Your First RMD Just Moved to 75, and That’s Two More Conversion Years Nobody Has Told You About.

Scott Bessent’s $1 Trillion Bond Market Fight — Treasury Yields Aren’t Buying It

Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips

Born in 1960 or Later? Your First RMD Just Moved to 75, and That's Two More Conversion Years Nobody Has Told You About.

He Answered Yes to One Question About Sleep Apnea. At 73, Every Medigap Insurer He Called Said No.

Gold and Bitcoin Surge on Treasury Bond Market Fight. Scarce Asset Owners Are This Market’s Big Winners

Born in 1960 or Later? Your First RMD Just Moved to 75, and That’s Two More Conversion Years Nobody Has Told You About.

Pfizer : PFE

All Pfizer Articles

Media Digest 8/7/2007 Reuters, WSJ, NYTimes, FT, Barron’s

PFizer’s (PFE) Promising New HIV Drug

NYSE Short Interest For July

Pre-Market Stock News (July 18, 2007)

Pfizer’s (PFE) Bad Hair Day

Top Earnings Next Week Part 1 (July 16-18, 2007)

Mixed Short Interest in Drug & Medical Stocks (June 2007)

DJIA Components Short Interest Mixed (June 2007)

Media Digest 6/22/2007 Reuters, WSJ, NYTimes, FT, Barron’s

NYSE Short Interest, June 2007

Media Digest 6/21/2007 Reuters, WSJ, NYTimes, FT, Barron’s

Coley Pharmaceutical (COLY): Another Biopharma Collapse

Biotech Implosion: Coley Pharmaceutical Group (COLY)

Cramer’s Picks & Pans in Pharmaceuticals

Market Trades For Super-Bulls, Chicken-Bulls, and Outright Bears

Born in 1960 or Later? Your First RMD Just Moved to 75, and That’s Two More Conversion Years Nobody Has Told You About.

Scott Bessent’s $1 Trillion Bond Market Fight — Treasury Yields Aren’t Buying It

Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips

Featured Reads

Born in 1960 or Later? Your First RMD Just Moved to 75, and That's Two More Conversion Years Nobody Has Told You About.

He Answered Yes to One Question About Sleep Apnea. At 73, Every Medigap Insurer He Called Said No.